In Addition to providing general cancer care for various cancers, our institute has created speciality group of highly skilled professionals devoted to a select group of cancers. The special focus is on cancer affecting children and women.
Cancer treatments are rapidly evolving and becoming increasingly complex. Smart selection of treatment that will surely be effective is the key to successful cancer treatment today. At NCI, we will provide clinical and laboratory infrastructure to health care professionals to practice the science of prediction in delivering cancer care.
• Molecular diagnostics
• Cancer genomics and bioinformatics
• Biomarker research
Precision at every level of cancer care, such as precision in radiation therapy, precision in extricating tumors through minimally invasive surgical techniques, and non surgical interventional approaches and developing and using latest targeted systematic therapies, will be emphasized at NCI, ensuring low risk and high efficiency.
• Advanced Imaging
• Interventional Radiology
• Therapeutic Nuclear Medicine
• Minimally Invasive and Robotic Surgery
• Access to Targeted Drugs and Rapid Availability of Novel Therapeutics
Of all the ways to control cancer, especially in India, we believe prevention and early diagnosis are the most important approaches. Through outreach programs, education of public and other health care professionals, we aim to spread and increase awareness about cancer, so as to prevent cancers linked to substance abuse, infections, lifestyle, and to increase awareness about importance of seeking medical attention early to enable early cancer diagnosis.
• Community outreach programs
• Health camps
• Educational activities for healthcare professionals
• Awareness programs in schools to “Catch them young” and prevent substance abuse and adopt healthy lifestyle
Every Participant is different and has unique needs in terms of disease characteristics, host characteristics, goals of treatment and much more. Patient care at NCI will reflect the same belief. Due importance will be given to develop a personalized treatment plan.
• Tumor Board approach for every patient
• Individual case managers
• Application of knowledge of Pharmacogenomics and Pharmacokinetics
• Identifying patient population with unique needs such as women, children, adolescents and very old patients.
At NCI, we will follow an approach to cancer care that identifies all stakeholders as Kark Yoddhas, from the hospital staff, physicians and nurses to family members and other caregivers. In addition, participation and collaboration within and outside the country to facilitate uniform evidence-based cancer care and high quality research will help us fight cancer.
• Active patient participation in treatment decisions
• Knowledge sharing
• Collaboration with leaders in the field of oncology
• Collaborative research
• Exhaustive data compilation
• Increasing participation of primary care physicians.
Launching ceremony of National Cancer Institute, Nagpur on 18th August 2012.
Bhoomi-Pujan of the new facility of National Cancer Institute on 28th Feb 2015 at the hands of Hon’ble Suresh alias Bhaiyyaji Joshi, Sarkaryawah, Rashtriya Swayamsewak Sangh, and Shri Devendra Fadnavis, Hon’ble Chief Minister, Government of Maharashtra.
Inauguration of phase 1 of National Cancer Institute at the hands of Padma Vibhushan Shri Ratan Tata, industrialist and philantrophist, Shri Devendra Fadnavis, Hon'ble Chief Minister of Maharastra, in august presence of Shri Nitin Gadkari, Minister of Road Transport and Highways , Shri Piyush Goyal, Minister of Coal and Renewable Energy and Shri Dharmendra Pradhan - Minister of Petroleum & Natural Gas and Minister of Steel and other dignitaries.
Inauguration of our dedicated 27 bedded Paediatric Ward at the hands of Dr P A Kurkure, MD, NH – SRCC Children’s Hospital, Mumbai & Dr S D Banavali, Professor & Head, Medical Oncology, TMH , Mumbai.
Inauguration of IPD private ward at the hands of Shri Devendra Fadnavis Hon'ble Chief Minister of Maharastra in the august presence of Mrs. Neerja Birla.
Tata Trusts, a philanthropic organisation known for its extensive work in cancer care came forward and pledged financial support to NCI, Nagpur to enable us to collectively expand our footprint in cancer care and research. The MoU was signed on 14th July, 2018.
Mr. Azim Premji, ex-chairman Wipro & philanthropist and Mr. Rishad Premji, Chairman, Wipro visited NCI on 5th October, 2019. Thoroughly impressed with the project and the Kark Yoddhas, Mr. Azim Premji said, "What is most impressive is the dedication of the people who work here right from the bottom to the CEO. It is very unique and dedicated to the cause."
'Ayushmati'- National Cancer Institute's flagship programme for womens' freedom from fear of cancer was commemorated on Womens' Day in august presence of Ms. Sonali Bendre, renowned Bollywood actress and a cancer survivor.
“Ayushmati” has been initiated upholding the 5P approach which is the core philosophy of NCI. We believe in taking Predictive, Precise, Preventive, Personalized and Participatory approach towards our fight against cancer. It can help educate the women upon imbibing the practices of self-care and advancements in cancer research. It also helps them access the right channels in order to take the first step towards freedom from cancer.
National Cancer Institute, Nagpur & Datta Meghe Institute of Medical Sciences (DMIMS), Nagpur have signed a Memorandum of Understanding (MoU) on 10th of August 2020 at National Cancer Institute, Nagpur. Dr Rajiv Borle, Vice Chancellor, DMIMS (DU), Dr Dilip Gode, Dean and Dr Babaji Ghewade, Registrar from DMIMS (DU) were present to sign the MoU.